Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023		Jul. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (104,107)		$ (88,110)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	78,698		55,218
Charitable donation of common stock	5,350		0
Amortization of intangible assets	1,125		1,176
Depreciation expense	2,206		1,286
Amortization of deferred contract acquisition costs	20,619		21,618
Gain from deconsolidation of Meltano Inc.	0		(17,798)
Loss from equity method investment	2,108		1,290
Net amortization of premiums or discounts on short-term investments	(8,494)		(1,293)
Unrealized foreign exchange loss (gain), net	825		(1,572)
Other non-cash (income) expense, net	(103)		469
Changes in assets and liabilities:
Accounts receivable	25,281		(13,568)
Prepaid expenses and other current assets	(4,248)		(5,488)
Deferred contract acquisition costs	(18,137)		(21,210)
Other long-term assets	(721)		2,700
Accounts payable	(1,023)		528
Accrued expenses and other current liabilities	1,183		90
Accrued compensation and benefits	2,611		(16,680)
Deferred revenue	11,175		17,549
Other non-current liabilities	1,800		(696)
Net cash provided by (used in) operating activities	16,148		(64,491)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(334,996)		(520,664)
Proceeds from maturities of short-term investments	272,984		50,031
Purchases of property and equipment	(533)		(3,234)
Deconsolidation of Meltano Inc.	0		(9,620)
Escrow payment related to business combination, after acquisition date	2,500		0
Net cash used in investing activities	(65,045)		(483,487)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	17,777		11,311
Issuance of common stock under employee stock purchase plan	7,751		9,554
Contributions received from noncontrolling interests, net of issuance costs	0		57,673
Net cash provided by financing activities	25,528		78,538
Impact of foreign exchange on cash and cash equivalents	(1,308)		(4,475)
Net decrease in cash and cash equivalents	(24,677)		(473,915)
Cash, cash equivalents, and restricted cash at beginning of period	297,902		887,172
Cash, cash equivalents, and restricted cash at end of period	273,225		413,257
Supplemental disclosure of cash flow information:
Cash paid for income taxes	4,187		309
Supplemental disclosure of non-cash investing and financing activities:
Vesting of early exercised stock options	809		2,960
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	273,225	[1]	410,757
Restricted cash, included in prepaid expenses and other current assets	0		2,500
Total cash, cash equivalents and restricted cash	$ 273,225		$ 413,257

[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.